Phathom Pharmaceuticals, Inc. PHAT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s accounts payable?
- Phathom Pharmaceuticals, Inc. (PHAT) reported accounts payable of $6.37M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s accounts payable decreased by 45.2% year-over-year, from $11.62M to $6.37M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s accounts payable has grown at a -21.6% compound annual growth rate (CAGR), from $16.78M to $4.98M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.